Proto Labs INC

Proto Labs announced record second quarter 2026 revenue of $149.3 million, a 10.6% increase year-over-year, and raised its full-year revenue growth guidance.

Proto Labs held its Annual Meeting of Shareholders on May 19, 2026, where key proposals including director elections, auditor ratification, executive compensation advisory vote, and an amendment to the 2022 Long-Term Incentive Plan were approved.

Proto Labs strengthens its executive team with the appointment of Bernardo Parlange as Chief Commercial Officer and announces the planned retirement of COO Mike Kenison.

Proto Labs, Inc. filed an amended 8-K to correct a scrivener's error, raising its GAAP diluted EPS guidance range for the first quarter of 2026.

Protolabs announced record fourth quarter and full year 2025 financial results, driven by strong CNC Machining growth and strategic transformation initiatives.

Protolabs reported record third-quarter 2025 revenue of $135.4 million, a 7.8% year-over-year increase, driven by strong performance in key end markets.

Proto Labs announced a 10.6% increase in revenue for the second quarter of 2026, driven by strong performance in CNC Machining and Injection Molding, alongside improved gross margins.

Proto Labs reported a 10.4% revenue increase to $139.3 million for Q1 2026, driven by strong CNC machining demand.

Protolabs reports a 7.8% increase in Q3 2025 revenue to $135.4 million, with net income remaining stable at $7.2 million, driven by strong CNC Machining growth.

Proto Labs, Inc. reported a 7.5% increase in Q2 2025 revenue to $135.1 million, alongside a 2.5% decrease in net income and a 0.7 percentage point decline in gross margin, as the company navigates a CEO transition and facility closures in Germany.

Proto Labs' Q1 2025 revenue decreased slightly compared to Q1 2024, with the company focusing on strategic adjustments and customer value.

Proto Labs' Q3 2024 results show a slight revenue decrease and a strategic restructuring in Germany, impacting financial performance.

Proto Labs' 2024 results reflect a slight revenue decrease alongside strategic decisions to close facilities and optimize operations.

Proto Labs Inc. has released its 10-K annual report, outlining its financial results, strategic direction, and operational activities for the fiscal year ended December 31, 2023.

Proto Labs Inc. director Sven Wehrwein reported the sale of 2,000 shares of common stock in a recent SEC Form 4 filing.

Proto Labs Inc. President and CEO Suresh Krishna reported a sale of 1,247 shares of common stock on May 23, 2026, for $71.36 per share.

Proto Labs CFO Daniel Schumacher disposed of 255 shares of common stock to cover tax withholding obligations.

Chief Commercial Officer Bernardo Parlange acquired 2,109 restricted stock units and 3,789 stock options as part of an equity compensation award.

Proto Labs Inc. reports a Form 4 filing detailing a transaction by Director Chand Sujeet, acquiring 2,210 shares of common stock.

Proto Labs Director Rainer Gawlick acquired 2,210 shares of common stock.

Proto Labs, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for May 19, 2026, detailing director elections, executive compensation votes, and an amendment to its long-term incentive plan.

Proto Labs, Inc. has filed a definitive proxy statement with the SEC.

Proto Labs is asking shareholders to approve an amendment to its long-term incentive plan to increase the number of shares available for issuance, following a year of strong financial results and strategic transformation.

Proto Labs, Inc. has filed a definitive proxy statement with the SEC.

Proto Labs is asking shareholders to approve an amended and restated long-term incentive plan to increase the number of shares available for issuance and extend the plan's term.

Disciplined Growth Investors Inc. has reported an increase in its beneficial ownership of Proto Labs Inc. common stock to 10.0%, holding 2,380,514 shares.

Vanguard Capital Management has reported a beneficial ownership of 5.1% in Proto Labs Inc. common stock as of March 31, 2026.

Vanguard Portfolio Management has reported a beneficial ownership of 6.51% in Proto Labs Inc. common stock as of March 31, 2026.

The Vanguard Group reported a 0% beneficial ownership in Proto Labs Inc. common stock following an internal realignment.

Disciplined Growth Investors, Inc. has disclosed a 10.9% beneficial ownership stake in Proto Labs Inc. common stock.

Disciplined Growth Investors, Inc. has reported a significant passive stake of 11.4% in Proto Labs Inc., holding over 2.7 million common shares.